OREANDA-NEWS. BMI View: Prospects for Singapore's healthcare sector will be robust. Supported by the government's consistent investments into the sector, the country has developed a strong research foundation which will in turn serve to augment Singapore's competitive edge in clinical trials and medical tourism. A strong healthcare sector will be advantageous for other sectors such as the logistics industry, and will support Singapore's long-term trade prospects as traditional drivers such as electronics face headwinds.

Headline Expenditure Projections

- Pharmaceuticals: SGD1.10bn (USD800mn) in 2015 to SGD1.16bn (USD820mn) by 2016; +5.4% in local currency terms and 2.9% in USD terms.

- Healthcare: SGD21.30bn (USD15.49bn) in 2015 to SGD23.53bn (USD16.71bn) by 2016; +10.5% in local currency terms and 7.8% in USD terms.